A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo
NCT05165329 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2024-02-08
Summary
At present there is no cure for food allergy. People with a food allergy need to avoid the food they are allergic to in order to stay safe. However we know that accidental exposure is common. Researchers have begun to look at the effectiveness of 'oral immunotherapy' as a treatment for food allergy but results have been mixed.
This study is a randomized controlled trial to evaluate the effectiveness of Probiotic and Peanut Oral Immunotherapy (PPOIT) in inducing tolerance in children with peanut allergy compared with Oral Immunotherapy (OIT) alone and with Placebo. Children will take increasing doses of peanut protein and a set amount of probiotic until a total of 18 months treatment is completed. Children will be tested for peanut allergy at the start of the study, at the end of PPOIT treatment T1 (18 months) and T2 (8 weeks) and T3 (1year) after treatment.
Conditions
- Peanut Allergy
- Food Allergy in Children
Interventions
- COMBINATION_PRODUCT
-
PEANUT OIT: Peanut Flour (50% peanut protein) that is prepared under food manufacturing regulations
PROBIOTIC: The probiotic to be used is Lactobacillus rhamnosus GG, supplied as a freeze-dried powder. Probiotic will be prepared under strict Food Manufacturing Regulations. The daily dose of 2x10\^10 cfu will be packed individually in sachets. Participants will be instructed to mix one scoop of the probiotic in water at a temperature NOT exceeding 38 degrees Celsius. The probiotic must be stored at 4 degrees Celsius
- COMBINATION_PRODUCT
-
PEANUT OIT: Peanut Flour (50% peanut protein) that is prepared under food manufacturing regulations
PROBIOTIC PLACEBO: Probiotic Placebo is maltodextrin. The daily dose will be measured using a standardised scoop. Participants will be instructed to mix one scoop of the probiotic in water at a temperature NOT exceeding 38 degrees Celsius. The probiotic should be stored at 2-8 degrees Celsius.
- COMBINATION_PRODUCT
-
PEANUT PLACEBO: Peanut Placebo is maltodextrin powder with food colouring and peanut essence that has similar appearance, taste and smell to the active product.
PROBIOTIC PLACEBO: Probiotic Placebo is maltodextrin. The daily dose will be measured using a standardised scoop. Participants will be instructed to mix one scoop of the probiotic in water at a temperature NOT exceeding 38 degrees Celsius. The probiotic should be stored at 2-8 degrees Celsius.
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Ting Fan Leung · Department of Paediatrics, The Chinese University of Hong Kong
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-11
- Primary Completion
- 2024-09-30
- Completion
- 2024-12-31
Countries
- Hong Kong
Study Locations
More Related Trials
-
Improving the Safety of Oral Immunotherapy for Cow's Milk Allergy
NCT02216175 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial for Wheat Oral Immunotherapy
NCT06069492 ·Status: RECRUITING ·Phase: NA
-
Food Oral Immunotherapy for Peanut Allergy
NCT04222491 ·Status: ACTIVE_NOT_RECRUITING
-
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
NCT03345160 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tolerance to Oral Peanut
NCT01259804 ·Status: COMPLETED ·Phase: PHASE1
-
Fish Oral Immunotherapy in Hong Kong Children
NCT05590299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
NCT01373242 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Sublingual Immunotherapy in Peanut-allergic Children
NCT00597727 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study
NCT02198664 ·Status: COMPLETED ·Phase: PHASE2
-
FARE Peanut SLIT and Early Tolerance Induction
NCT02304991 ·Status: COMPLETED ·Phase: PHASE2
-
Immune-supportive Diet and Gut Permeability in Allergic Children
NCT05667610 ·Status: RECRUITING ·Phase: NA
-
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
NCT03736447 ·Status: COMPLETED ·Phase: PHASE3
-
Boiled Peanut Immunotherapy for the Treatment of Peanut Allergy
NCT03937726 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT
NCT04511494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy
NCT03907397 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Immunotherapy in Young Children With Food Allergy
NCT05738798 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical and Biological Efficacy of Peanut Oral Immunotherapy
NCT02979600 ·Status: COMPLETED
-
Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety
NCT06256146 ·Status: RECRUITING ·Phase: NA
-
Mechanisms of Desensitization During Peanut Oral Immunotherapy
NCT01814241 ·Status: COMPLETED ·Phase: PHASE2
-
Sustained Unresponsiveness (SU) to Sesame Protein Following Low-dose Oral Allergen-specific Immunotherapy
NCT07107451 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sublingual Immunotherapy for Food Allergy
NCT00736281 ·Status: TERMINATED ·Phase: NA
-
Single Center Food Allergy Oral Immunotherapy Study
NCT01490177 ·Status: COMPLETED ·Phase: PHASE1
-
Early Peanut Introduction: Translation to Clinical Practice
NCT03019328 ·Status: COMPLETED
-
Persistence of Oral Tolerance to Peanut
NCT01366846 ·Status: COMPLETED ·Phase: PHASE2
-
Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance
NCT01996774 ·Status: COMPLETED